Quantcast

Latest nausea Stories

2008-01-29 15:00:13

Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved EMEND(R) (fosaprepitant dimeglumine) for Injection, a new intravenous therapy for the prevention of chemotherapy-induced nausea and vomiting (CINV). EMEND for Injection is an intravenous prodrug of the oral formulation of EMEND(R) (aprepitant), which means that when EMEND for Injection is administered, fosaprepitant is rapidly converted in the body to aprepitant. EMEND for Injection is approved...

2008-01-08 09:00:19

NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced that George Moonsammy, Ph.D. has been appointed Vice President of Development. Dr. Moonsammy has more than 30 years of domestic and international expertise in clinical studies. Dr. Moonsammy most recently served as Senior Vice President, Clinical, Regulatory, and Medical Affairs at Somerset Pharmaceuticals, Tampa,...

2007-06-07 06:00:13

By Kutlu, Tayfun; Tugrul, Semih; Aydin, Arzu; Oral, zay Hyperemesis gravidarum is a severe and intractable form of nausea and vomiting in pregnancy. The peak incidence is at 8-12 weeks of pregnancy, and symptoms usually resolve by week 16. The diagnosis of hyperemesis is easily made from clinical data; however, it is sometimes hard to diagnose because of accompanying symptoms and because other complex diseases may present with hyperemesis. An 18-year-old woman presented with complaints of...

2006-12-20 18:00:13

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) recently approved INVANZ® (ertapenem), a once-daily injectable antibiotic, for the prophylaxis of surgical site infection (SSI) following elective colorectal surgery in adults. This approval was based upon the results of the landmark PREVENT trial, the largest prospective, randomized double-blind, comparative clinical trial ever conducted in antibiotic prophylaxis for elective...

2006-08-30 07:24:44

NEW YORK (Reuters) - Cancer-focused biotechnology firm Hana Biosciences said on Wednesday the U.S. Food and Drug Administration had accepted Zensana Oral Spray for review. The company said it expects Zensana, a drug aimed at preventing chemotherapy, radiation, and post-operative associated nausea and vomiting, to be launched in the United States in the first half of 2007, subject to FDA approval.

2006-05-23 13:35:00

By Ransdell Pierson NEW YORK (Reuters) - Shares of Wyeth fell on Tuesday following the disclosure that an experimental anti-depressant, which was designed to be improvement over its top-selling Effexor XR drug, caused nausea in many patients in a clinical trial. Wyeth shares were down $1.25, or 2.6 percent, to $47.58 in afternoon trading on the New York Stock Exchange. Data from a late-stage trial of the anti-depressant, called DVS-233, were presented on Monday at a scientific meeting of the...

a74426173e4e1616ea23c40fd26a81461
2006-05-02 08:00:00

NEW YORK -- Acupuncture, in conjunction with the latest drugs to prevent nausea and vomiting, seems to help relieve chemotherapy-induced vomiting, a new report suggests. Despite the advent of new drug that control nausea and vomiting related to chemotherapy (anti-emetics), many cancer patients still experience these unpleasant side effects, which can impair quality of life, cause emotional distress, and aggravate cancer-related symptoms such as weight loss, lethargy and weakness. The ancient...

2006-01-16 12:40:00

NEW YORK -- Medical data suggest that at a dose of at least 1 gram of ginger is effective in preventing the nausea and vomiting that often afflicts patients after undergoing surgery. Numerous studies have looked at a variety of agents for preventing postoperative nausea and vomiting, yet none have been accepted as a gold standard for this use, according to the report in the American Journal of Obstetrics and Gynecology. Ginger has been used as a traditional medicine in China to treat nausea,...

2005-12-28 13:19:43

NEW YORK (Reuters Health) - Cyclical vomiting syndrome is well recognized in children, but now new research indicates that it can affect adults as well. With cyclical vomiting syndrome, patients experience nausea and vomiting lasting several hours or even days. These episodes are separated by symptom-free intervals usually lasting for weeks or months, according to a report in the journal BMC Medicine. In the present study, Dr. David R. Fleisher, from the University of Missouri...

2005-10-26 00:45:51

By Karla Gale NEW YORK (Reuters Health) - For people undergoing surgery, recovery could be easier with a new anti-nausea drug. Aprepitant, made by Merck Research Laboratories, reduces the rate of vomiting during the first 48 hours after open abdominal surgery, according to a trial reported this week at the meeting of the American Society of Anesthesiologists in Atlanta. The drug is already approved by the US Food and Drug Administration for treatment of chemotherapy-induced nausea...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'